In this time of dire need, Sepragen team is doing its part to solve the problem of COVID-19. We are providing equipment on an expedited basis to a company developing a vaccine for COVID- 19.
Skip to Main Content
About Us
About Us
Adsorptive Radial Column Filtration (ARCF)
Applications
Automating Your Process Development
Bio Reactor
Careers
Chromatography Columns
Chromatography Resins
Chromatography Systems
Column Packing
Contact Us
Customer Service
Full List
Gradient Formation
Home
Knowledge Center
Learning Center
News
News and Events Archives
Privacy Policy
Product selector tool
Product(s) with selected parameters
Products
Products
QS Buffer Dilution System
QS Column Packing System
QuantaSep® 100
QuantaSep® 1000 LC
QuantaSep® Specifications
Quotes
Scaling Up
SepraFlo® Media
SepraSorb® Applications
SepraSorb® Media
Single Use Chromatography System
Superflo® Column Applications
Superflo® Column Scaling-Up Applications
Superflo® Lab Scale Columns
Superflo® Pilot Scale Column
Superflo® Process Scale Column
Technical Support
Terms and Conditions
Versaflo® Axial Column
Vlog / Blog
WEDGE® Column
info@sepragen.com
Products
Chromatography Automated Systems
Chromatography Columns
Chromatography Resin
Column Packing Systems
Column Packing service
Buffer Preparations System
Customized Engineering
Accessories
Applications
Biologics Drug Manufacturing
Enabling Biologics Drug Scale up
Health Enhancing Human Nutrition
Services
Technical Support
Customer Service
About
Learning Center
News & Events
Vlog / Blog
Contact
Careers
Quotes
Product selector tool
Select all that is applicable
Cell Culture Harvest Volume or Buffer Volume
January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
3L and Below
3L to 50L
50L to 200L
200L to 500L
500L to 2000L
2000L to 4000L
4000L and above
Single-use (choose one)
January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Yes
No
Continuous (choose one)
January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Yes
No
Inline Buffer Dilution (choose one)
January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Yes
No
Inline Buffer Blending (choose one)
January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Yes
No
Radial Flow Column (choose one)
January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Yes
No
Perfusion
January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
Up to 200L/day
Up to 2000L/day
Maximum System Flowate
January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
1 ml/min – 300 ml/min
10ml/min – 2LPM
100ml/min – 5LPM
250ml/min – 10LPM
1LPM – 16LPM
16LPM – 60LPM
60LPM – 125LPM
Column Diameter
January 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications.
< 5cm
5cm – 15cm
10cm – 30cm
25cm – 40cm
30cm – 100cm
45cm – 1.5M
1M – 2M
Submit
Products
Chromatography Automated Systems
Chromatography Columns
Chromatography Resin
Column Packing Systems
Column Packing service
Buffer Preparations System
Customized Engineering
Accessories
Applications
Biologics Drug Manufacturing
Enabling Biologics Drug Scale up
Health Enhancing Human Nutrition
Services
Technical Support
Customer Service
About
Learning Center
News & Events
Vlog / Blog
Contact
Careers
Quotes